P/E ratio for Swedish Orphan Biovitrum (SOBI.ST)
P/E ratio as of April 2025 (TTM): 36.3
According to Swedish Orphan Biovitrum's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 36.2793. At the end of 2022 the company had a P/E ratio of 30.0.
P/E ratio history for Swedish Orphan Biovitrum from 2009 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | 30.0 | 50.57% |
| 2021 | 20.0 | 35.12% |
| 2020 | 14.8 | 10.17% |
| 2019 | 13.4 | -39.53% |
| 2018 | 22.2 | -14.48% |
| 2017 | 25.9 | -25.34% |
| 2016 | 34.7 | -93.87% |
| 2015 | 566 | -808.97% |
| 2014 | -79.9 | -57.83% |
| 2013 | -189 | 108.71% |
| 2012 | -90.8 | -169.08% |
| 2011 | 131 | -284.05% |
| 2010 | -71.4 | -186.12% |
| 2009 | 82.9 |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.